@vybion.com
Vybion, Inc. is a development stage company.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Vybion is an innovative brand at the forefront of antibody technology. They specialize in developing vectorized Intrabodies, which are functional antibody fragments delivered to cells using Adeno-associated virus (AAV) in the scFv format. With their groundbreaking approach, Vybion has achieved significant advancements in treating Huntington's disease, a debilitating condition characterized by protein aggregation and neuronal loss.
Recognized for their exceptional work, Vybion has been granted Orphan Drug Designation by the FDA for their product INT41, specifically designed to target Huntington's disease. This recognition highlights the brand's commitment to tackling this progressively fatal condition. Through a recent preIND meeting, Vybion has established a clear roadmap for IND enabling work, which will pave the way for upcoming human clinical trials.
By combining cutting-edge technology with a focus on patient care, Vybion is pioneering new treatment options for Huntington's disease and providing hope for those affected by this devastating condition. To learn more about Vybion's pipeline, partnerships, and licensing opportunities, visit their website today. Stay updated with the latest news and developments as Vybion continues to make significant strides in the field of antibody innovations
Company Type
Privately Held
Company Size
2-10
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories